Publications by authors named "Halford S"

Article Synopsis
  • The study investigates how a novel CHK1 inhibitor, SRA737, affects cancer cell lines with different P53 gene statuses, focusing on non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) cell lines.
  • CHK1 is activated in response to DNA damage, allowing damaged cells to pause their cycle; inhibiting CHK1 aims to make these cells more susceptible to treatment by preventing this pause.
  • Results show that cancer cells with mutated P53 were more sensitive to SRA737, exhibiting increased DNA damage and reduced proliferation compared to wild-type cells, highlighting the importance of P53 status in cancer treatment response.
View Article and Find Full Text PDF

X-linked retinoschisis (XLRS) is the most common juvenile macular degeneration in males. Unlike most other X-linked retinal dystrophies, carrier heterozygous females are very rarely reported to show clinical features of the disease. Herein, we describe unusual retinal features in a 2-year-old female infant with family history and genetic testing consistent with XLRS.

View Article and Find Full Text PDF

Diabetic Retinopathy (DR) is a leading cause of preventable visual impairment in the working age population. Despite the increasing prevalence of DR, there remain gaps in our understanding of its pathophysiology. This is a prospective case-control study comparing the genetic profiles of patients with no DR vs.

View Article and Find Full Text PDF
Article Synopsis
  • Modern cancer therapies are targeting specific aspects of cancer for better effectiveness and tolerability, but many still face issues with side effects and overall tolerability.
  • The traditional maximum tolerated dose (MTD) model may no longer be suitable, prompting a move towards a more holistic approach for determining optimal dosing in early clinical trials.
  • The FDA's Project Optimus and international collaborations through Project Orbis are working on optimizing dose selection and improving patient access to new cancer therapies, emphasizing the need for reform in how early phase oncology trials are conducted.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates AZD3965, a novel inhibitor of monocarboxylate transporter 1 (MCT1), intended to evaluate its safety and effectiveness in treating advanced cancers in patients with no standard treatment options.
  • During the trial's dose escalation, 40 patients were treated, with common side effects including mild fatigue and changes in retinal function; dose-limiting toxicities mainly occurred at higher doses.
  • The findings suggest that AZD3965 is generally well-tolerated at effective doses, establishing an optimal dosage of 10 mg twice daily for further testing in cancers with high MCT1 expression.
View Article and Find Full Text PDF
Article Synopsis
  • Public health crises, like HIV and COVID-19, significantly change the political dynamics for vulnerable groups in society.
  • Research involved interviews with leaders of organizations supporting sex workers, sexual minorities, and transgender individuals in India, who adapted their strategies during both pandemics.
  • The article highlights how these crises affected funding, advocacy efforts, and collaboration within social movements, indicating that lessons learned from the HIV crisis informed responses to the challenges posed by COVID-19.
View Article and Find Full Text PDF

Background: This study aimed to compare phenotype−genotype correlation in patients with Usher syndrome (USH) to those with autosomal recessive retinitis pigmentosa (NS-ARRP) caused by genes associated with Usher syndrome. Methods: Case notes of patients with USH or NS-ARRP and a molecularly confirmed diagnosis in genes associated with Usher syndrome were reviewed. Phenotypic information, including the age of ocular symptoms, hearing impairment, visual acuity, Goldmann visual fields, fundus autofluorescence (FAF) imaging and spectral domain optical coherence tomography (OCT) imaging, was reviewed.

View Article and Find Full Text PDF

The aim of this review article is to describe the specific features of Stargardt disease and retinopathies (ABCA4R) using multimodal imaging and functional testing and to highlight their relevance to potential therapeutic interventions. Standardised measures of tissue loss, tissue function and rate of change over time using formal structured deep phenotyping in Stargardt disease and ABCA4R are key in diagnosis, and prognosis as well as when selecting cohorts for therapeutic intervention. In addition, a meticulous documentation of natural history will be invaluable in the future to compare treated with untreated retinas.

View Article and Find Full Text PDF

Background: To establish the molecular diagnosis in two brothers presenting with the ocular features of Knobloch Syndrome using whole genome sequencing (WGS).

Methods: Clinical examination and ophthalmological phenotyping were completed under general anaesthesia. DNA samples were tested on a targeted retinal dystrophy next-generation sequencing panel.

View Article and Find Full Text PDF

Stargardt disease (STGD1) and retinopathies (ABCA4R) are caused by pathogenic variants in the gene inherited in an autosomal recessive manner. The gene encodes an importer flippase protein that prevents the build-up of vitamin A derivatives that are toxic to the RPE. Diagnosing ABCA4R is complex due to its phenotypic variability and the presence of other inherited retinal dystrophy phenocopies.

View Article and Find Full Text PDF

Objectives: The primary objective is to evaluate the efficacy of camostat to prevent respiratory deterioration in patients with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Secondary objectives include assessment of the ability of camostat to reduce the requirement for Coronavirus disease 2019 (COVID-19) related hospital admission and to reduce the requirement for supplementary oxygen and ventilation as treatment for SARS-CoV-2 infection, to evaluate overall mortality related to COVID-19 and to evaluate the efficacy of camostat by effect on clinical improvement. Research objectives include to assess change in COVID-19 symptom severity, to evaluate the ability of camostat to reduce viral load throughout duration of illness as well as translational research on host and viral genomics, serum antibody production, COVID-19 diagnostics, and validation of laboratory testing methods and biomarkers.

View Article and Find Full Text PDF

Background: We present 3 members of a family with macular dystrophy, originally diagnosed as Stargardt disease, with a significantly variable age at onset, caused by a heterozygous mutation in CRX.

Case Presentation: A 43-year-old female with bull's eye maculopathy, whose sister was diagnosed with Stargardt disease previously at another centre, was found to have a single ABCA4 variant. Further examination of the family revealed that the asymptomatic father was also affected, indicating a dominant pattern of inheritance.

View Article and Find Full Text PDF

Autosomal recessive retinitis pigmentosa is caused by mutations in over 40 genes, one of which is the ceramide kinase-like gene (). We present a case series of six patients from six unrelated families diagnosed with inherited retinal dystrophies (IRD) and with two variants in recruited from a multi-ethnic British population. A retrospective review of clinical data in these patients was performed and included colour fundus photography, fundus autofluorescence (AF) imaging, spectral domain-optical coherence tomography (SD-OCT), visual fields and electroretinogram (ERG) assessment where available.

View Article and Find Full Text PDF

A retrospective review of the clinical records of patients seen at the Oxford Eye Hospital identified as having mutations was performed. The data included symptoms, best-corrected visual acuity, multimodal retinal imaging, visual fields and electrophysiology testing. Three participants were identified with biallelic pathogenic sequence variants detected using a targeted NGS gene panel, two of which were novel.

View Article and Find Full Text PDF

Engaging students in class when first-hand experience is not available is challenging. Three teaching strategies, flipped classroom, a guest speaker, and technology, engaged students during a global health class. Students were given a graded preclass assignment, which was used to guide the class session when an expert physician from Zambia joined us using technology.

View Article and Find Full Text PDF

Background And Objectives: The EYS gene is an important cause of autosomal recessive retinitis pigmentosa (arRP). The objective of this study is to report on novel pathogenic variants in EYS and the range of associated phenotypes.

Subjects And Methods: This retrospective case series at a tertiary referral centre for inherited retinal diseases describes patients with an IRD and at least two variants in the EYS gene.

View Article and Find Full Text PDF
Article Synopsis
  • - The OPARATIC trial investigated how well the PARP inhibitor olaparib penetrates recurrent glioblastoma tumors and its safety when combined with low-dose TMZ chemotherapy.
  • - Preclinical studies showed that olaparib did not penetrate the brain well in rats but was successfully found in human tumor samples, with 36% of patients remaining progression-free at six months after treatment.
  • - While olaparib was effective at radiosensitizing glioblastoma cells, it also increased the hematological side effects of TMZ, leading to a recommended dose regimen of olaparib (150 mg) three times a week alongside TMZ (75 mg/m² daily) for 42 days.
View Article and Find Full Text PDF

As right-wing populist movements make electoral gains around the world, one might expect that resultant policy and legislative reversals against sexual and reproductive health and rights (SRHR) would be mirrored by a similar backlash in United Nations (UN) human rights negotiations. Yet the past five years have seen unprecedented advances for SRHR within the UN Human Rights Council (HRC), treaty bodies, and special procedures. In this article, we provide an overview of SRHR gains and setbacks within the HRC and analyse their broader significance, particularly as socially conservative nation states and non-governmental organisations seek to challenge them.

View Article and Find Full Text PDF

Importance: Detailed phenotypic information on the spectrum of fundus abnormalities and clinical variability of all phenotypes associated with sequence variations in BEST1 is limited.

Objective: To report a detailed phenotypic and genetic analysis of a patient cohort with sequence variations in BEST1.

Design, Setting, And Participants: This retrospective case series took place at the Oxford Eye Hospital in Oxford, UK.

View Article and Find Full Text PDF

Since the publication of this paper the authors noticed an error in the listed authors, where Alexandros Siskos was listed as Alexandros Sitkos. This has now been corrected.

View Article and Find Full Text PDF

A 47-year-old man with metastatic melanoma presented with refractory hyperlactaemic acidosis following the first dose of the mono-carboxylase transporter 1 inhibitor AZD3965 within a "first time in man" clinical trial. The mechanism of the agent and the temporal relationship suggested that this event was potentially drug related and recruitment was suspended. However, urinary metabolomics showed extensive abnormalities even prior to drug administration, leading to investigations for an underlying metabolic disorder.

View Article and Find Full Text PDF

Regulation of cell type-specific gene expression is critical for generating neuronal diversity. Transcriptome analyses have unraveled extensive heterogeneity of transcribed sequences in retinal photoreceptors because of alternate splicing and/or promoter usage. Here we show that Frmpd1 (FERM and PDZ domain containing 1) is transcribed from an alternative promoter specifically in the retina.

View Article and Find Full Text PDF

Purpose: Mutations in encoding ADP-ribosylation factor-like 2 binding protein, have recently been implicated as a cause of autosomal recessive retinitis pigmentosa (arRP), with three homozygous variants identified to date. In this study, we performed next-generation sequencing to reveal additional arRP cases associated with variants.

Methods: Whole-genome sequencing (WGS) or whole-exome sequencing (WES) was performed in 1,051 unrelated individuals recruited for the UK Inherited Retinal Disease Consortium and NIHR-BioResource Rare Diseases research studies.

View Article and Find Full Text PDF